Selected research
Market Structure
Global Drug Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Drug Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Drug Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Drug Testing include Siemens Healthcare, Thermo Fisher Scientific, Roche Diagnostics, Quest Diagnostics, Shimadzu, Quest Diagnostics, Laboratory Corporation of America MPD, KGAA Alere and Express Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Drug Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Drug Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Drug Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Drug Testing Segment by Company
Siemens Healthcare
Thermo Fisher Scientific
Roche Diagnostics
Quest Diagnostics
Shimadzu
Quest Diagnostics
Laboratory Corporation of America MPD
KGAA Alere
Express Diagnostics
Drgerwerk AG & Co.
Drug Testing Segment by Type
Hair Sample
Breath Sample
Oral Fluid
Urine Sample
Others
Drug Testing Segment by Application
Personal Users
Workplace and Schools
Pain Management Centers
Criminal Justice System & Law Enforcement Agencies
Drug Testing Laboratories
Drug Treatment Centers
Hospitals
Drug Testing Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drug Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug Testing industry.
Chapter 3: Detailed analysis of Drug Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Hair Sample
- Breath Sample
- Oral Fluid
- Urine Sample
- Others
Applications
- Personal Users
- Workplace and Schools
- Pain Management Centers
- Criminal Justice System & Law Enforcement Agencies
- Drug Testing Laboratories
- Drug Treatment Centers
- Hospitals
Companies covered
- Siemens Healthcare
- Thermo Fisher Scientific
- Roche Diagnostics
- Quest Diagnostics
- Shimadzu
- Quest Diagnostics
- Laboratory Corporation of America MPD
- KGAA Alere
- Express Diagnostics
- Drgerwerk AG & Co.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Drug Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Hair Sample
- 1.2.3 Breath Sample
- 1.2.4 Oral Fluid
- 1.2.5 Urine Sample
- 1.2.6 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Drug Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Personal Users
- 1.3.3 Workplace and Schools
- 1.3.4 Pain Management Centers
- 1.3.5 Criminal Justice System & Law Enforcement Agencies
- 1.3.6 Drug Testing Laboratories
- 1.3.7 Drug Treatment Centers
- 1.3.8 Hospitals
- 1.4 Global Market Growth Prospects
- 1.5 Global Drug Testing Growth Trends by Region
- 1.5.1 Global Drug Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Drug Testing Market Size by Region (2021-2026)
- 1.5.3 Drug Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Drug Testing Market Dynamics
- 2.1 Drug Testing Industry Trends
- 2.2 Drug Testing Industry Drivers
- 2.3 Drug Testing Industry Opportunities and Challenges
- 2.4 Drug Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Drug Testing Revenue by Company (2021-2026)
- 3.2 Global Drug Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Drug Testing Key Company Head office and Area Served
- 3.4 Global Drug Testing Company, Product Type & Application
- 3.5 Global Drug Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Drug Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Drug Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 Drug Testing Tier 1, Tier 2, and Tier 3
4 Drug Testing Market by Type
- 4.1 Global Drug Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Drug Testing Market Size by Type (2021-2032)
- 4.3 Global Drug Testing Market Size Share by Type (2021-2032)
5 Drug Testing Market by Application
- 5.1 Global Drug Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Drug Testing Market Size by Application (2021-2032)
- 5.3 Global Drug Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Siemens Healthcare
- 6.1.1 Siemens Healthcare Company Information
- 6.1.2 Siemens Healthcare Business Overview
- 6.1.3 Siemens Healthcare Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Siemens Healthcare Drug Testing Product Portfolio
- 6.1.5 Siemens Healthcare Recent Developments
- 6.2 Thermo Fisher Scientific
- 6.2.1 Thermo Fisher Scientific Company Information
- 6.2.2 Thermo Fisher Scientific Business Overview
- 6.2.3 Thermo Fisher Scientific Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Thermo Fisher Scientific Drug Testing Product Portfolio
- 6.2.5 Thermo Fisher Scientific Recent Developments
- 6.3 Roche Diagnostics
- 6.3.1 Roche Diagnostics Company Information
- 6.3.2 Roche Diagnostics Business Overview
- 6.3.3 Roche Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Roche Diagnostics Drug Testing Product Portfolio
- 6.3.5 Roche Diagnostics Recent Developments
- 6.4 Quest Diagnostics
- 6.4.1 Quest Diagnostics Company Information
- 6.4.2 Quest Diagnostics Business Overview
- 6.4.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Quest Diagnostics Drug Testing Product Portfolio
- 6.4.5 Quest Diagnostics Recent Developments
- 6.5 Shimadzu
- 6.5.1 Shimadzu Company Information
- 6.5.2 Shimadzu Business Overview
- 6.5.3 Shimadzu Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Shimadzu Drug Testing Product Portfolio
- 6.5.5 Shimadzu Recent Developments
- 6.6 Quest Diagnostics
- 6.6.1 Quest Diagnostics Company Information
- 6.6.2 Quest Diagnostics Business Overview
- 6.6.3 Quest Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Quest Diagnostics Drug Testing Product Portfolio
- 6.6.5 Quest Diagnostics Recent Developments
- 6.7 Laboratory Corporation of America MPD
- 6.7.1 Laboratory Corporation of America MPD Company Information
- 6.7.2 Laboratory Corporation of America MPD Business Overview
- 6.7.3 Laboratory Corporation of America MPD Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Laboratory Corporation of America MPD Drug Testing Product Portfolio
- 6.7.5 Laboratory Corporation of America MPD Recent Developments
- 6.8 KGAA Alere
- 6.8.1 KGAA Alere Company Information
- 6.8.2 KGAA Alere Business Overview
- 6.8.3 KGAA Alere Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 KGAA Alere Drug Testing Product Portfolio
- 6.8.5 KGAA Alere Recent Developments
- 6.9 Express Diagnostics
- 6.9.1 Express Diagnostics Company Information
- 6.9.2 Express Diagnostics Business Overview
- 6.9.3 Express Diagnostics Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Express Diagnostics Drug Testing Product Portfolio
- 6.9.5 Express Diagnostics Recent Developments
- 6.10 Drgerwerk AG & Co.
- 6.10.1 Drgerwerk AG & Co. Company Information
- 6.10.2 Drgerwerk AG & Co. Business Overview
- 6.10.3 Drgerwerk AG & Co. Drug Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Drgerwerk AG & Co. Drug Testing Product Portfolio
- 6.10.5 Drgerwerk AG & Co. Recent Developments
7 North America
- 7.1 North America Drug Testing Market Size (2021-2032)
- 7.2 North America Drug Testing Market Size by Type
- 7.2.1 North America Drug Testing Market Size by Type (2021-2026)
- 7.2.2 North America Drug Testing Market Size by Type (2027-2032)
- 7.2.3 North America Drug Testing Market Share by Type (2021-2032)
- 7.3 North America Drug Testing Market Size by Application
- 7.3.1 North America Drug Testing Market Size by Application (2021-2026)
- 7.3.2 North America Drug Testing Market Size by Application (2027-2032)
- 7.3.3 North America Drug Testing Market Share by Application (2021-2032)
- 7.4 North America Drug Testing Market Size by Country
- 7.4.1 North America Drug Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Drug Testing Market Size by Country (2021-2026)
- 7.4.3 North America Drug Testing Market Size by Country (2027-2032)
- 7.4.4 North America Drug Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Drug Testing Market Size (2021-2032)
- 8.2 Europe Drug Testing Market Size by Type
- 8.2.1 Europe Drug Testing Market Size by Type (2021-2026)
- 8.2.2 Europe Drug Testing Market Size by Type (2027-2032)
- 8.2.3 Europe Drug Testing Market Share by Type (2021-2032)
- 8.3 Europe Drug Testing Market Size by Application
- 8.3.1 Europe Drug Testing Market Size by Application (2021-2026)
- 8.3.2 Europe Drug Testing Market Size by Application (2027-2032)
- 8.3.3 Europe Drug Testing Market Share by Application (2021-2032)
- 8.4 Europe Drug Testing Market Size by Country
- 8.4.1 Europe Drug Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Drug Testing Market Size by Country (2021-2026)
- 8.4.3 Europe Drug Testing Market Size by Country (2027-2032)
- 8.4.4 Europe Drug Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Drug Testing Market Size (2021-2032)
- 9.2 China Drug Testing Market Size by Type
- 9.2.1 China Drug Testing Market Size by Type (2021-2026)
- 9.2.2 China Drug Testing Market Size by Type (2027-2032)
- 9.2.3 China Drug Testing Market Share by Type (2021-2032)
- 9.3 China Drug Testing Market Size by Application
- 9.3.1 China Drug Testing Market Size by Application (2021-2026)
- 9.3.2 China Drug Testing Market Size by Application (2027-2032)
- 9.3.3 China Drug Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Drug Testing Market Size (2021-2032)
- 10.2 Asia Drug Testing Market Size by Type
- 10.2.1 Asia Drug Testing Market Size by Type (2021-2026)
- 10.2.2 Asia Drug Testing Market Size by Type (2027-2032)
- 10.2.3 Asia Drug Testing Market Share by Type (2021-2032)
- 10.3 Asia Drug Testing Market Size by Application
- 10.3.1 Asia Drug Testing Market Size by Application (2021-2026)
- 10.3.2 Asia Drug Testing Market Size by Application (2027-2032)
- 10.3.3 Asia Drug Testing Market Share by Application (2021-2032)
- 10.4 Asia Drug Testing Market Size by Country
- 10.4.1 Asia Drug Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Drug Testing Market Size by Country (2021-2026)
- 10.4.3 Asia Drug Testing Market Size by Country (2027-2032)
- 10.4.4 Asia Drug Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Drug Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Drug Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa Drug Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Drug Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Drug Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Drug Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa Drug Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Drug Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Drug Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Drug Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa Drug Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Drug Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Drug Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Drug Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst